Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2010
10/21/2010US20100267753 Methods of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267747 5-(Arylsulfonyl)-Pyrazolopiperidines
10/21/2010US20100267746 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
10/21/2010US20100267743 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010US20100267740 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842
10/21/2010US20100267739 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
10/21/2010US20100267738 Novel amide and amidine derivatives and uses thereof
10/21/2010US20100267737 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/21/2010US20100267733 Synergistic Modulation of Microglial Activation by Nicotine and THC
10/21/2010US20100267730 Novel compounds
10/21/2010US20100267728 3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
10/21/2010US20100267727 Pharmaceutical formulations comprising neurotrophin mimetics
10/21/2010US20100267723 Imidazole Substituted Pyrimidines
10/21/2010US20100267721 Heterocyclic H3 Antagonists
10/21/2010US20100267720 Crystalline Forms of 2-Hydroxy-3- [5- (Morpholin- 4- Ylmethyl) Pyridin-2-YL] IH- Indole- 5 -Carbonitrile Citrate
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267704 Autophagy Inducing Compounds and Uses Thereof in Treating Autophagy Associated Diseases
10/21/2010US20100267701 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267695 Fused indane compound
10/21/2010US20100267691 Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
10/21/2010US20100267690 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
10/21/2010US20100267687 Phenylpyrazole derivatives
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267669 Heterocyclic cetp inhibitors
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267648 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267632 Treatment of neurodegenerative disorders
10/21/2010US20100267626 Methods and compositions for measuring wnt activation and for treating wnt-related cancers
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100267618 Methods for treating congestive heart failure
10/21/2010US20100267614 Prodrugs of Peripheral Phenolic Opioid Antagonists
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/21/2010US20100266714 P2x3 receptor antagonists for treatment of pain
10/21/2010US20100266711 Thienobenzodiazepine modulators of d1 receptor, d2 receptor, and/or 5-ht2 receptor
10/21/2010US20100266684 Method and composition for administering an nmda receptor antagonist to a subject
10/21/2010US20100266682 Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
10/21/2010US20100266655 Sustained delivery formulations of risperidone compounds
10/21/2010US20100266645 Pharmaceutical compositions
10/21/2010US20100266638 Headache treatment method
10/21/2010US20100266623 Synthetic, self adjuvanting vaccines
10/21/2010US20100266596 Therapeutic antibody purification method and method of use
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266581 Compositions and methods for modulating s-nitrosogluthione reductase
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266571 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
10/21/2010US20100266569 Prostatic acid phosphatase for the treatment of pain
10/21/2010US20100266554 Methods and composition for treating neural degeneration
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266528 Systemic Administration of Colony Stimulating Factors to Treat Amyloid Associated Disorders
10/21/2010US20100266509 Heteroaryl amide analogues as p2x7 antagonists
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/21/2010US20100266490 Metalloproteinase Binding Proteins
10/21/2010CA2761064A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010CA2758855A1 Compounds for the treatment of mitochondrial diseases
10/21/2010CA2758852A1 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010CA2758774A1 Monoamine reuptake inhibitors
10/21/2010CA2758772A1 Indole derivative modulators of the alpha 7 nachr
10/21/2010CA2758367A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2758321A1 5-ht4 receptor agonist compounds for treatment of cognitive disorders
10/21/2010CA2757351A1 Anti-mental fatigue drug
10/20/2010EP2241885A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241567A1 Bicycloamine derivative
10/20/2010EP2241561A1 Neuroprotective, hypocholesterolemic and antiepileptic compound
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241316A1 Indolone compounds useful to treat cognitive impairment
10/20/2010EP2241315A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
10/20/2010EP2240492A1 Process for the preparation of asenapine and intermediate products used in said process
10/20/2010EP2240485A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
10/20/2010EP2240481A1 (1-azinone) -substituted pyridoindoles as mch antagonists
10/20/2010EP2240480A2 Derivatives of 2-heteroaroyl-imidazol(1,2-a)pyridine,preparation thereof and therapeutic application thereof
10/20/2010EP2240476A1 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors
10/20/2010EP2240474A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/20/2010EP2240472A1 2-amino-quinoline derivatives useful as inhibitors of -secretase (bace)
10/20/2010EP2240468A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/20/2010EP2240467A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
10/20/2010EP2240458A1 Aryl sulfonamides as effective analgesics
10/20/2010EP2240448A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/20/2010EP2240431A1 Crystalline modifications of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl -propyl)-phenol
10/20/2010EP2240189A1 Microvesicles
10/20/2010EP2240177A2 Treatments for neuropathy
10/20/2010EP2240173A1 Delayed release pharmaceutical composition of duloxetine
10/20/2010EP2240028A1 Organic compounds
10/20/2010EP2029594B1 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use
10/20/2010EP1951653B1 Salicylic acid derivatives
10/20/2010EP1948166B1 Carbazole derivatives as functional 5-ht6 ligands
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1699759B1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
10/20/2010EP1407269B1 A method for diagnosing a person having multiple sclerosis
10/20/2010EP1373502B1 Dopaminergic neuronal survival-promoting factors and uses thereof
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
1 ... 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 ... 1833